An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression

赛马鲁肽 杜拉鲁肽 医学 优势比 2型糖尿病 荟萃分析 糖化血红素 内科学 内分泌学 糖尿病 艾塞那肽 利拉鲁肽
作者
Ildiko Lingvay,Robert Bauer,James Baker‐Knight,Jack Lawson,Richard E. Pratley
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
卷期号:107 (5): 1461-1469 被引量:9
标识
DOI:10.1210/clinem/dgab905
摘要

Abstract Aims Currently, no head-to-head data are available comparing semaglutide 2.0 mg with dulaglutide 3.0 mg or 4.5 mg. We conducted an indirect treatment comparison (ITC) of their effects on glycated hemoglobin (HbA1c) and body weight in patients with type 2 diabetes. Materials and methods Multilevel network meta-regression was conducted, based on a connected evidence network of published results from the A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes 11 trial and individual patient data from the A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN) and SUSTAIN 7 trials. Results Semaglutide 2.0 mg significantly reduced HbA1c vs dulaglutide 3.0 mg and 4.5 mg, with estimated treatment differences (ETDs) of –0.44% points (95% credible interval [CrI], –0.68 to –0.19) and –0.28% points (95% CrI, –0.52 to –0.03), respectively. Semaglutide 2.0 mg also significantly reduced body weight vs dulaglutide 3.0 mg and 4.5 mg with ETDs of –3.29 kg (95% CrI, –4.62 to −1.96) and –2.57 kg (95% CrI, –3.90 to –1.24), respectively. Odds of achieving HbA1c < 7.0% were significantly greater for semaglutide 2.0 vs dulaglutide 3.0 mg (odds ratio [OR]: 2.23 [95% CrI, 1.15-3.90]), whereas this did not reach significance for semaglutide 2.0 mg vs dulaglutide 4.5 mg (OR: 1.58 [95% CrI, 0.82-2.78]). Sensitivity analyses supported the main analysis findings. Conclusions This ITC demonstrated significantly greater reductions from baseline in HbA1c and body weight with semaglutide 2.0 mg vs dulaglutide 3.0 mg and 4.5 mg. The findings of this study provide important comparative effectiveness information until randomized head-to-head studies become available.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yujie完成签到,获得积分10
刚刚
timber乾杯发布了新的文献求助30
刚刚
我是老大应助shinn采纳,获得30
刚刚
九天揽月发布了新的文献求助50
2秒前
2秒前
Orange应助冷艳芯采纳,获得10
3秒前
Orange应助bei采纳,获得10
3秒前
5秒前
Adel完成签到 ,获得积分10
6秒前
6秒前
8秒前
wss123456发布了新的文献求助10
8秒前
9秒前
10秒前
大个应助泡泡糖采纳,获得10
11秒前
思源应助DY采纳,获得10
11秒前
Rita发布了新的文献求助10
12秒前
猪猪hero应助麻辣烫小姐采纳,获得10
12秒前
蓝色的梦发布了新的文献求助10
12秒前
13秒前
wbj0722完成签到,获得积分10
13秒前
shinn发布了新的文献求助30
13秒前
量子星尘发布了新的文献求助10
14秒前
fivezcy发布了新的文献求助10
15秒前
萧水白应助liberty采纳,获得10
17秒前
18秒前
pipi发布了新的文献求助10
19秒前
20秒前
zhouz发布了新的文献求助10
21秒前
21秒前
小北完成签到,获得积分10
23秒前
23秒前
独特冰安发布了新的文献求助10
23秒前
一杯沧海完成签到 ,获得积分10
23秒前
25秒前
李健应助寡核苷酸小白采纳,获得10
25秒前
慕青应助shinn采纳,获得10
26秒前
LuckyJ_Jia发布了新的文献求助10
26秒前
26秒前
Ashley完成签到,获得积分10
26秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975339
求助须知:如何正确求助?哪些是违规求助? 3519670
关于积分的说明 11199199
捐赠科研通 3256002
什么是DOI,文献DOI怎么找? 1798043
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305